Item 8.01. Other Events.
As previously reported, on December 10, 2020, AquaBounty Technologies, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Oppenheimer & Co. Inc. and Lake Street Capital Markets, LLC, as the representatives of the underwriters named therein (the “Underwriters”), relating to the underwritten public offering (the “Offering”) at a public offering price of $6.50 per share of up to an aggregate of 10,028,000 shares of the Company’s common stock (the “Shares”), which includes an over-allotment option granted to the Underwriters, exercisable for 30 days, to purchase up to 1,308,000 shares.
On December 14, 2020, the Company consummated the sale of the Shares at a public offering price of $6.50 per share, including the full exercise of the underwriters’ over-allotment option, generating gross proceeds of approximately $65.2 million. After deducting underwriting discounts and commissions, the net proceeds to the Company from the Offering were approximately $60.4 million.
The Offering and sale of the Shares was made pursuant to a prospectus supplement dated December 10, 2020, which is part of the Company’s Registration Statement on Form S-3 (File No. 333-224184), which was filed on April 6, 2018; amended on April 23, 2018; and declared effective by the Securities and Exchange Commission on April 27, 2018; and a related registration statement on Form S-3 (File No. 333- 251257) filed on December 10, 2020 pursuant to Rule 462(b) under the Securities Act of 1933, as amended.
On December 14, 2020, the Company issued a press release regarding the closing of the Offering. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.